These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis. Ward JR Am J Med; 1988 Oct; 85(4A):39-44. PubMed ID: 3052055 [TBL] [Abstract][Full Text] [Related]
5. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739 [TBL] [Abstract][Full Text] [Related]
6. Drugs for rheumatoid arthritis. Med Lett Drugs Ther; 1991 Jul; 33(848):65-70. PubMed ID: 1676134 [No Abstract] [Full Text] [Related]
7. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721 [TBL] [Abstract][Full Text] [Related]
8. Drugs for rheumatoid arthritis. Med Lett Drugs Ther; 1989 Jun; 31(795):61-4. PubMed ID: 2567489 [No Abstract] [Full Text] [Related]
9. Drug treatment of arthritis. Update on conventional and less conventional methods. Spencer-Green G Postgrad Med; 1993 May; 93(7):129-40. PubMed ID: 8493195 [TBL] [Abstract][Full Text] [Related]
10. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis. Clegg DO; Ward JR Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451 [TBL] [Abstract][Full Text] [Related]
11. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments. Simon LS Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314 [TBL] [Abstract][Full Text] [Related]
12. Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis. Pugh MC; Pugh CB Clin Pharm; 1987 Jun; 6(6):475-91. PubMed ID: 3319362 [TBL] [Abstract][Full Text] [Related]
14. [Drug therapy of rheumatoid arthritis]. Arndt U; Rittmeister M; Möller B Orthopade; 2003 Dec; 32(12):1095-103. PubMed ID: 14655006 [TBL] [Abstract][Full Text] [Related]
15. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. Wolfe F; Hawley DJ; Cathey MA J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological management of juvenile rheumatoid arthritis. Rose CD; Doughty RA Drugs; 1992 Jun; 43(6):849-63. PubMed ID: 1379157 [TBL] [Abstract][Full Text] [Related]
17. Therapy for rheumatoid arthritis: combinations of disease-modifying drugs and new paradigms of treatment. Wilke WS; Clough JD Semin Arthritis Rheum; 1991 Oct; 21(2 Suppl 1):21-34. PubMed ID: 1749946 [TBL] [Abstract][Full Text] [Related]
18. The role of anti-malarials in rheumatoid arthritis--the American experience. Khraishi MM; Singh G Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910 [TBL] [Abstract][Full Text] [Related]